v2.4.0.8
CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Details 3) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net cash provided by (used in) operating activities $ (1,575) $ 35,882
Cash flows from investing activities:    
Capital expenditures (55,599) (39,350)
Investments in non-consolidated entities, net (721) (2,671)
Acquisition of Rave theatres, net of cash acquired   (315)
Proceeds (payments) from the disposition of long-term assets (128) 4,991
Other, net (1,783) (956)
Net cash used in investing activities (58,231) (38,301)
Cash flows from financing activities:    
Proceeds from issuance of Senior Subordinated Notes due 2022 375,000  
Repurchase of Senior Subordinated Notes due 2019 (496,903)  
Payment of initial public offering costs (281)  
Deferred financing costs (7,568) (175)
Principal payments under capital and financing lease obligations (1,672) (1,511)
Principal payments under Term Loan (1,938) (2,001)
Change in construction payables   (20,541)
Net cash used in financing activities (133,362) (24,228)
Effect of exchange rate changes on cash and equivalents (9) (48)
Net decrease in cash and equivalents (193,177) (26,695)
Cash and equivalents at beginning of period 544,311 130,928
Cash and equivalents at end of period 351,134 104,233
Reportable Entity | AMCE
    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 15,308 28,805
Cash flows from financing activities:    
Proceeds from issuance of Senior Subordinated Notes due 2022 375,000  
Repurchase of Senior Subordinated Notes due 2019 (496,903)  
Deferred financing costs (7,568) (175)
Principal payments under Term Loan (1,938) (2,001)
Change in intercompany advances 116,181 (26,638)
Net cash used in financing activities (15,228) (28,814)
Net decrease in cash and equivalents 80 (9)
Cash and equivalents at beginning of period 485 308
Cash and equivalents at end of period 565 299
Reportable Entity | Subsidiary Guarantors
    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (16,429) 3,951
Cash flows from investing activities:    
Capital expenditures (55,562) (39,345)
Investments in non-consolidated entities, net (721) (2,665)
Acquisition of Rave theatres, net of cash acquired   (315)
Proceeds (payments) from the disposition of long-term assets (128) 4,991
Other, net (1,783) (956)
Net cash used in investing activities (58,194) (38,290)
Cash flows from financing activities:    
Payment of initial public offering costs (281)  
Principal payments under capital and financing lease obligations (1,672) (1,511)
Change in intercompany advances (116,542) 29,656
Change in construction payables   (20,541)
Net cash used in financing activities (118,495) 7,604
Effect of exchange rate changes on cash and equivalents (53) (57)
Net decrease in cash and equivalents (193,171) (26,792)
Cash and equivalents at beginning of period 501,989 89,168
Cash and equivalents at end of period 308,818 62,376
Reportable Entity | Subsidiary Non-Guarantors
    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (454) 3,126
Cash flows from investing activities:    
Capital expenditures (37) (5)
Investments in non-consolidated entities, net   (6)
Net cash used in investing activities (37) (11)
Cash flows from financing activities:    
Change in intercompany advances 361 (3,018)
Net cash used in financing activities 361 (3,018)
Effect of exchange rate changes on cash and equivalents 44 9
Net decrease in cash and equivalents (86) 106
Cash and equivalents at beginning of period 41,837 41,452
Cash and equivalents at end of period $ 41,751 $ 41,558